US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Havilah Resources Limited (HAV) 銘柄情報

Havilah Resources Limited (HAV)

0.73

-0.015

(-2.01%)

終了 7月3日 3:00PM

Havilah Resources Limited (HAV) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.73

( -2.01% )

買値

0.715

売値

0.75

出来高

297,717

0.715 日の範囲 0.745

0.17 52 週間の範囲 0.77

時価総額

前日終値

0.745

始値

0.73

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 350,001

発行済株式数

353,972,407

配当利回り

PER

-77.17

1 株当たり利益 (EPS)

-0.01

歳入

-

純利益

-3.2M

Havilah Resources Limited, together with its subsidiaries, engages in the exploration and evaluation of mineral exploration tenements and mining leases in Australia. The company explores for copper, gold, cobalt, uranium, tungsten, molybdenum, and iron ore deposits, as well as rare earth elements. I... Havilah Resources Limited, together with its subsidiaries, engages in the exploration and evaluation of mineral exploration tenements and mining leases in Australia. The company explores for copper, gold, cobalt, uranium, tungsten, molybdenum, and iron ore deposits, as well as rare earth elements. Its flagship properties are the Grants and Maldorky iron ore, the Kalkaroo gold-copper-cobalt, and the Mutooroo copper-cobalt projects located in northeastern South Australia. Havilah Resources Limited was founded in 1996 and is based in Kent Town, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

www.havilah-resources.com.au

本社

Kent Town, Australia

設立

1996

Havilah Resources Limited is listed in the Materials sector of the オーストラリア証券取引所 with ticker HAV. The last closing price for Havilah Resources was AUD0.75. Over the last year, Havilah Resources shares have traded in a share price range of AUD 0.17 to AUD 0.77.

Havilah Resources currently has 353,972,407 shares in issue. The market capitalisation of Havilah Resources is AUD258.40 million. Havilah Resources has a price to earnings ratio (PE ratio) of -77.17.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0125	1.74216027875	0.7175	0.75	0.705	265117	0.73339762	DE
4	0.055	8.14814814815	0.675	0.77	0.615	553782	0.71317885	DE
12	0.14	23.7288135593	0.59	0.77	0.56	372184	0.67668047	DE
26	0.145	24.7863247863	0.585	0.77	0.51	448313	0.6415355	DE
52	0.56	329.411764706	0.17	0.77	0.17	424569	0.51555601	DE
156	0.51	231.818181818	0.22	0.77	0.135	228079	0.39870594	DE
260	0.515	239.534883721	0.215	0.77	0.135	243019	0.34185239	DE

HAV - Frequently Asked Questions (FAQ)

What is the current Havilah Resources Limited share price?

The current share price of Havilah Resources Limited is AUD 0.73

How many Havilah Resources Limited shares are in issue?

Havilah Resources Limited has 353,972,407 shares in issue

What is the market cap of Havilah Resources Limited?

The market capitalisation of Havilah Resources Limited is AUD 258.4M

What is the 1 year trading range for Havilah Resources Limited share price?

Havilah Resources Limited has traded in the range of AUD 0.17 to AUD 0.77 during the past year

What is the PE ratio of Havilah Resources Limited?

The price to earnings ratio of Havilah Resources Limited is -77.17

What is the registered address of Havilah Resources Limited?

The registered address for Havilah Resources Limited is 107 Rundle Street, Kent Town, South Australia, 5067

What is the Havilah Resources Limited website address?

The website address for Havilah Resources Limited is www.havilah-resources.com.au

Which industry sector does Havilah Resources Limited operate in?

Havilah Resources Limited operates in the Mining sector

Seminole Red

Seminole Red 14分前

Ruined VW’s - purist not allowed

Almost positive it’s ruined.

https://www.facebook.com/reel/1768850754281751

Ray_137

Ray_137 18分前

Any news about the date of 30th June 2026?

SkeBallLarry

SkeBallLarry 19分前

% Happy 4th to you, Getmore ~ Thanks 4 All % ..

OliXPharma_Official

OliXPharma_Official 27分前

Global pharma interest in RNAi therapeutics continues to accelerate.

According to BioSpace, AstraZeneca has entered into a collaboration with CSPC Pharmaceutical Group to discover and develop siRNA therapeutics for kidney diseases. The deal is reportedly worth up to $1.77 billion, inc

Pittsburgh Boy

Pittsburgh Boy 28分前

Umm no that's why I asked, thanks

diamondguru-one

diamondguru-one 32分前

On September 30th…

President Trump is set to declare this miracle material a national strategic resource. And ban it as a U.S. expor t.

That means every major tech company on the planet will be forced to come here — to U.S. soil — to get it.

Apple, NVI

sentiment_stocks

sentiment_stocks 59分前

If the mOS of the control arm drops, wouldn’t that increase the difference between the two?

I do wonder if the MAIC was, in the end, simply more conservative due to its weighting than the patient level scoring?

Kool Aid Man

Kool Aid Man 1時間前

Gullible goobers actually believe they'd own Patagroania..smh

BeachBum

BeachBum 1時間前

30 mil, pay attention.

europa7

europa7 1時間前

Europe's MiCA Deadline Leaves Four in Five Crypto Firms Without a Licence
1 July 2026
https://www.sandmark.com/news/features/europes-mica-deadline-leaves-four-five-crypto-firms-without-licence

"...The transitional window closed on 1 Jul, and the grace period that let nat

GseHeist

GseHeist 1時間前

Looks like AL4ZR is playing F2 soccer on the FiFA sidelines. Very very dangerous game he is playing and he doesn't belong here.

nowwhat2

nowwhat2 2時間前

https://investorshub.advfn.com/uimage/uploads/2026/7/3/ljz[qbtc_july_2_10y_10pm_GEE_200_60.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7/3/qbfzqbtc_july_2_1y_200_60k_zoom.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7

along4zride

along4zride 2時間前

He is in a league the garden variety penny pinching stock holder cannot comprehend. There is little empathy for (FNMA) bottom feeders.Never has been and never will be .

sometimes_right

sometimes_right 2時間前

The remaining bank defendants contesting LIBOR multi-billion-dollar appellate battle, along with those that have completely settled out of the primary investor tracks, are detailed below.

The Remaining Banks Involved in the Appeal
The specific financial institutions that did no

ZeroGravitas

ZeroGravitas 2時間前

JFB,
I know a lot of investors B&H QQQ but I think TQQQ is used more by traders. I know some that may go in and out of TQQQ based on the technical indicators for QQQ. I just think that there is a very small universe of investors with the stomach to hold on through a +70% drawdown. AIM will st

firebag1

firebag1 2時間前

Yup this is a 50 bagger in the making imo

firebag1

firebag1 2時間前

Yup. Good post. Lots of eyes will be on this

firebag1

firebag1 2時間前

Huge is all I can say.
I’m extremely bullish on this stock
Best wishes to you all
Happy 4th of July!!
250 big anniversary!!! Lol

Genz2

Genz2 2時間前

https://www.theregister.com/legal/2026/07/02/startup-sues-palo-alto-networks-koi-security-saying-an-ai-hallucinated-report-falsely-linked-it-to-chinese-espionage/5266201

flipper44

flipper44 2時間前

What you are suggesting is impossible. The delta can increase, which might happen, but the patient level data (arm) cannot increase the treatment arm median survival.

Edit: I see someone else already pointed this out to you.

thistraderknowsall

thistraderknowsall 2時間前

BTC TO $125K...NOM Crypto...not in Kansas anymore..MASSIVE short squeeeeeeeeze to $1 underway!!The next RAVE..RUNNER
No brainer.. enjoy the gains!

wronginvestor

wronginvestor 2時間前

Was always just a publicity stunt.

surfer44

surfer44 2時間前

Why Oil Prices Are Diverging from Fundamentals

https://youtu.be/OakeC8zQzJM

flipper44

flipper44 2時間前

Get some sleep everyone. Tomorrow will wait. Market Holiday! You have all weekend to take it in.

GritsWalabe

GritsWalabe 2時間前

Wrapped up a great green week. $SNTX has the share structure you want and multiple revenue generating companies. This company is bound for bigger boards.

Havilah Resources

Kingston Resources

Evans and Partners Globa...

Australian Strategic Mat...

La Trobe Financial Capit...

Avira Resources

Tennant Minerals

Gascoyne Resources

Capricorn Metals

Proteomics International...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。